checkAd

    DGAP-News  575  0 Kommentare CORRECTION: CVR Medical Granted IRB Approval by Thomas Jefferson University - Seite 2


    various risks and uncertainties regarding future events related to the
    Joint Venture. Such statements are subject to risks and uncertainties that
    may cause actual results, performance or developments to differ materially
    from those contained in the statements and are not guarantees of future
    performance of the Company. No assurance can be given that any of the
    events anticipated by the forward-looking statements will occur or, if they
    do occur, what benefits the Company will obtain from them. These
    forward-looking statements reflect management's current views and are based
    on certain expectations, estimates and assumptions which may prove to be
    incorrect. A number of risks and uncertainties could cause our actual
    results to differ materially from those expressed or implied by the
    forward-looking statements, including: (1) a downturn in general economic
    conditions in North America and internationally, (2) the inherent
    uncertainties and speculative nature associated with commercialization of
    technology and the practice of medicine, (3) a change in health
    regulations, (4) any number of events or causes which may delay or cease
    commercialization and development of the Joint Venture, (5) the risk that
    the Company or the Joint Venture does not execute its business plan, (6)
    inability to retain key employees, (7) inability to finance operations and
    growth, and (8) other factors beyond the Company's control. These
    forward-looking statements are made as of the date of this news release
    and, except as required by law, the Company assumes no obligation to update
    these forward-looking statements, or to update the reasons why actual
    results differed from those projected in the forward-looking statements.

    THE TSX VENTURE EXCHANGE INC. HAS NEITHER APPROVED NOR DISAPPROVED THE
    CONTENTS OF THIS PRESS RELEASE. NEITHER THE TSX VENTURE EXCHANGE NOR ITS
    REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF
    THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
    ACCURACY OF THIS RELEASE.

    Click on, or paste the following link into your web browser, to view
    the associated documents

    http://www.newsfilecorp.com/release/24578

    News Source: Newsfile














    18.01.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de

















    Language: English
    Company: CVR Medical Corp.
    Canada
    ISIN: CA1266321084





     
    End of News DGAP News Service





    537303  18.01.2017 




    Seite 2 von 2




    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News CORRECTION: CVR Medical Granted IRB Approval by Thomas Jefferson University - Seite 2 DGAP-News: CVR Medical Corp. / Key word(s): Miscellaneous CORRECTION: CVR Medical Granted IRB Approval by Thomas Jefferson University 18.01.2017 / 09:01 The issuer is solely responsible for the content of this announcement. Vancouver, British …